Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer? Reply

被引：1
|
作者：
Dowsett, M [1 ]
Cuzick, J
Wale, C
Howell, T
Houghton, J
Baum, M
Buzdar, A
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England
[3] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[4] UCL Hosp NHS Trust, London, England
[5] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 09期
关键词：
D O I：
10.1200/JCO.2005.05.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1482 / 1482
页数：1
相关论文
共 50 条
  • [21] Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
    Cobain, Erin F.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3673 - +
  • [22] Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Shen, Le-Sang
    Jin, Xiao-Yan
    Wang, Xu-Meng
    Tou, Lai-Zhen
    Huang, Jian
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1099 - 1108
  • [23] Breast cancer molecular subtypes defined by estrogen receptor progesterone receptor and human epidermal growth factor receptor type 2 status: Association with clinicopathologic parameters in Ivorian patients
    Effi, A.
    Arnim, N.
    Kour, B.
    Kofti, K.
    Traore, Z.
    Kouyate, M.
    VIRCHOWS ARCHIV, 2016, 469 : S63 - S63
  • [24] A comparative analysis of body mass index with estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in pre- and postmenopausal breast cancer patients
    Chauhan, Richa
    Trivedi, Vinita
    Rani, Rita
    Singh, Usha
    JOURNAL OF MID-LIFE HEALTH, 2020, 11 (04) : 210 - 216
  • [25] Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
    Walter, Vincent
    Fischer, Chiara
    Deutsch, Thomas M.
    Ersing, Catherine
    Nees, Juliane
    Schuetz, Florian
    Fremd, Carlo
    Grischke, Eva-Maria
    Sinn, Peter
    Brucker, Sara Y.
    Schneeweiss, Andreas
    Hartkopf, Andreas D.
    Wallwiener, Markus
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 137 - 144
  • [26] Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
    Vincent Walter
    Chiara Fischer
    Thomas M. Deutsch
    Catherine Ersing
    Juliane Nees
    Florian Schütz
    Carlo Fremd
    Eva-Maria Grischke
    Peter Sinn
    Sara Y. Brucker
    Andreas Schneeweiss
    Andreas D. Hartkopf
    Markus Wallwiener
    Breast Cancer Research and Treatment, 2020, 183 : 137 - 144
  • [27] Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer
    Alataki, Anastasia
    Dowsett, Mitch
    ENDOCRINE-RELATED CANCER, 2022, 29 (08) : R105 - R122
  • [28] Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India
    Kumar, Rekha Vijay
    Panwar, Dipti
    Amirtham, Usha
    Premalata, Chennagiri Srinivasmurthy
    Gopal, Champaka
    Narayana, Suma Mysore
    Okaly, Geetha Vikram Patil
    Lakshmaiah, K. C.
    Krishnamurthy, S.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 7 - 10
  • [29] Re: Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor-targeted therapy
    Ferretti, Gianluigi
    Felici, Alessandra
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (21): : 1644 - 1644
  • [30] Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer
    Qin Qinghong
    Gao Fangfang
    Jiang Wei
    Tan Qixing
    Mo Qinguo
    Wei Changyuan
    CHINESE MEDICAL JOURNAL, 2014, 127 (18) : 3272 - 3277
12345